U.S.C. homeSearch U.S. Code
U.S. CodeTitle 21Chapter 9— Federal Food, Drug, And Cosmetic ActSubchapter IX— Tobacco Products

21 U.S.C. § 387a (2026)

FDA authority over tobacco products

Edition and currency
U.S. Code current through Pub. L. 119-102 (OLRC release point). The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTU.S. Code current through Pub. L. 119-102 (OLRC release point) ACTIVE · 29 IN 5Y cited 2010–2026 59citing cases
At a glance

Courts have cited this section in 59 opinions since 2010, 29 of them in the last five years. The most litigated part is subsection (b) (37 cases).

(a) In general

Tobacco products, including modified risk tobacco products for which an order has been issued in accordance with section 387k of this title, shall be regulated by the Secretary under this subchapter and shall not be subject to the provisions of subchapter V.

(b) Applicability

This subchapter shall apply to all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco and to any other tobacco products that the Secretary by regulation deems to be subject to this subchapter. This subchapter shall also apply to any tobacco product containing nicotine that is not made or derived from tobacco.

(c) Scope(1) In general

Nothing in this subchapter, or any policy issued or regulation promulgated thereunder, or in sections 101(a), 102, or 103 of title I, title II, or title III of the Family Smoking Prevention and Tobacco Control Act, shall be construed to affect, expand, or limit the Secretary’s authority over (including the authority to determine whether products may be regulated), or the regulation of, products under this chapter that are not tobacco products under subchapter V or any other subchapter.

(2) Limitation of authority(A) In general

The provisions of this subchapter shall not apply to tobacco leaf that is not in the possession of a manufacturer of tobacco products, or to the producers of tobacco leaf, including tobacco growers, tobacco warehouses, and tobacco grower cooperatives, nor shall any employee of the Food and Drug Administration have any authority to enter onto a farm owned by a producer of tobacco leaf without the written consent of such producer.

(B) Exception

Notwithstanding subparagraph (A), if a producer of tobacco leaf is also a tobacco product manufacturer or controlled by a tobacco product manufacturer, the producer shall be subject to this subchapter in the producer’s capacity as a manufacturer. The exception in this subparagraph shall not apply to a producer of tobacco leaf who grows tobacco under a contract with a tobacco product manufacturer and who is not otherwise engaged in the manufacturing process.

(C) Rule of construction

Nothing in this subchapter shall be construed to grant the Secretary authority to promulgate regulations on any matter that involves the production of tobacco leaf or a producer thereof, other than activities by a manufacturer affecting production.

(d) Rulemaking procedures

Each rulemaking under this subchapter shall be in accordance with chapter 5 of title 5. This subsection shall not be construed to affect the rulemaking provisions of section 102(a) of the Family Smoking Prevention and Tobacco Control Act [21 U.S.C. 387a–1(a)].

(e) Center for tobacco products

Not later than 90 days after June 22, 2009, the Secretary shall establish within the Food and Drug Administration the Center for Tobacco Products, which shall report to the Commissioner of Food and Drugs in the same manner as the other agency centers within the Food and Drug Administration. The Center shall be responsible for the implementation of this subchapter and related matters assigned by the Commissioner.

(f) Office to assist small tobacco product manufacturers

The Secretary shall establish within the Food and Drug Administration an identifiable office to provide technical and other nonfinancial assistance to small tobacco product manufacturers to assist them in complying with the requirements of this chapter.

(g) Consultation prior to rulemaking

Prior to promulgating rules under this subchapter, the Secretary shall endeavor to consult with other Federal agencies as appropriate.

(June 25, 1938, ch. 675, § 901, as added Pub. L. 111–31, div. A, title I, § 101(b)(3), June 22, 2009, 123 Stat. 1786; amended Pub. L. 117–103, div. P, title I, § 111(b), Mar. 15, 2022, 136 Stat. 789.)Editorial NotesReferences in Text

The Family Smoking Prevention and Tobacco Control Act, referred to in subsec. (c)(1), is div. A of Pub. L. 111–31, June 22, 2009, 123 Stat. 1776. Section 101(a) of title I of the Act amended section 321 of this title. Section 102 of title I of the Act enacted section 387a–1 of this title. Section 103 of title I of the Act amended sections 331, 333, 334, 355, 360m, 372 to 374, 375, 379a, 381, 393, 399, and 679 of this title and enacted provisions set out as notes under sections 331, 333, and 387c of this title. Title II of the Act amended sections 1333, 1334, 4402, and 4406 of Title 15, Commerce and Trade, and enacted provisions set out as notes under sections 1333 and 4402 of Title 15. Title III of the Act enacted section 387t of this title. For complete classification of this Act to the Code, see Short Title of 2009 Amendment note set out under section 301 of this title and Tables.

Prior Provisions

A prior section 901 of act June 25, 1938, was renumbered section 1001 and is classified to section 391 of this title.

Amendments

2022—Subsec. (b). Pub. L. 117–103 inserted at end “This subchapter shall also apply to any tobacco product containing nicotine that is not made or derived from tobacco.”

Statutory Notes and Related SubsidiariesEffective Date of 2022 Amendment

Amendment by Pub. L. 117–103 effective 30 days after Mar. 15, 2022, see section 111(c) of Pub. L. 117–103, div. P, title I, Mar. 15, 2022, 136 Stat. 789, set out as a note under section 321 of this title.

The 20 cases that cite 21 U.S.C. § 387a most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENNicopure Labs, LLC v. Food & Drug Admin., 266 F. Supp. 3d 360 (D.D.C. 2017).
cites § 387a 6×subsections: (b) 4×cited by 13 cases
Where it cites § 387a
“” TCA § 901, codified at- 21 U.S.C. § 387a. This unequivocal assignment of responsibility goes on to provide: This chapter shall apply to all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco and to any other tobacco products that the Secretary by…”
Later courts cite it for
“just as an empty fountain pen is obviously a 'component' of an ink pen . . . even when the ink is sold separately,” · 2 citing courts
2
GREENSottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010).
cites § 387a 6×subsections: (a) 4× (c) 2×cited by 30 cases
Where it cites § 387a
“" 21 U.S.C. § 387a(a). Moreover, unlike Brown & Williamson, which used the term "tobacco products" without defining it, the Tobacco Control Act includes a definition: "The term `tobacco product' means any product made or derived from tobacco that is intended for human…”
Later courts cite it for
“whether (1) the plaintiff has a substantial likelihood of success on the merits; (2) the plaintiff would suffer irreparable injury were an injunction not granted; (3) an injunction would substantially injure other interested parties; and (4) the grant of an injunction would further the public interest.” · 6 citing courts
3
GREENBig Time Vapes, Inc. v. FDA, 963 F.3d 436 (5th Cir. 2020).
cites § 387a 2×subsections: (b) 2×cited by 27 cases
Where it cites § 387a
“at 1786 (codified at 21 U.S.C. § 387a(b)). Each of those terms is statutorily defined.”
The case’s holding
A statutory delegation is constitutional if the act provides an intelligible principle by delineating a general policy of protecting public health and preventing youth access to tobacco products.
Later courts cite it for
“the pmta process is onerous, requiring manufacturers to gather significant amounts of information.” · 3 citing courts
4
GREENR.J. Reynolds Tobacco Co. v. Phil J. Marotta, 214 So. 3d 590 (Fla. 2017).
cites § 387a 2×cited by 17 cases
Where it cites § 387a
“1776 (2009), codified as 21 U.S.C. § 387a (2012), which grants the Food and Drug Administration (FDA) authority to regulate cigarettes, but specifically prohibits the FDA from banning them.”
The case’s holding
Federal law does not implicitly preempt state law strict liability and negligence claims based on the intentional manipulation of nicotine levels in cigarettes.
Later courts cite it for
“where intradistrict conflict exists, the decision later in time overrules the former as the decisional law of the district” · 2 citing courts
5
GREENColgate v. Juul Labs, Inc., 345 F. Supp. 3d 1178 (N.D. Cal. 2018).
cites § 387a 2×subsections: (a)cited by 15 cases
Where it cites § 387a
“A, § 2 (codified at 21 U.S.C. § 387a )(2009). On May 10, 2016, the FDA issued a final rule titled "Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale…”
6
GREENWages & White Lion Invst v. FDA, 16 F.4th 1130 (5th Cir. 2021).
cites § 387a 1×subsections: (b)cited by 53 cases
Where it cites § 387a
“See 21 U.S.C. §§ 387a(b), 393(d)(2). The TCA prohibits manufacturers from selling any “new tobacco product” without authorization.”
The case’s holding
Regulatory compliance costs are unrecoverable and do not constitute irreparable harm because federal agencies generally enjoy sovereign immunity from monetary damages.
Later courts cite it for
“because federal agencies generally enjoy sovereign immunity for any monetary damages” · 12 citing courts
7
GREENSmoking Everywhere, Inc. v. U.S. Food & Drug Admin., 680 F. Supp. 2d 62 (D.D.C. 2010).
cites § 387a 2×subsections: (a) (c)cited by 16 cases
Where it cites § 387a
“” 21 U.S.C. § 387a(a). 6 . The Court notes that the FDCA defines a "device” along the same lines as a "drug.”
Later courts cite it for
“the party seeking a preliminary injunction need not prevail on each factor.” · 2 citing courts
8
GREENCigar Ass'n of Am. v. FDA, 964 F.3d 56 (D.C. Cir. 2020).
cites § 387a 1×subsections: (b)cited by 20 cases
Where it cites § 387a
“21 U.S.C. § 387a(b). The FDCA also now extends to “any other tobacco products” that the Secretary of Health and Human Services “by regulation deems to be subject to” the FDCA.”
Later courts cite it for
“instructs a reviewing court to set aside agency action found to be 'arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with law,” · 13 citing courts
9
GREENNicopure Labs, LLC v. FDA, 944 F.3d 267 (D.C. Cir. 2019).
cites § 387a 1×subsections: (b)cited by 18 cases
Where it cites § 387a
“21 U.S.C. § 387a(b). In addition to a default premarket authorization pathway, Congress created a more rigorous pathway for modified risk tobacco products.”
The case’s holding
The agency's reliance on a seller's claims to classify a product as a modified risk tobacco product does not burden the seller's speech.
Later courts cite it for
“the fda has expressed willingness to accept scientific literature reviews instead of commissioned studies in support of e-cigarette applications in appropriate circumstances.” · 2 citing courts
10
GREENMajor v. R.J. Reynolds Tobacco Co., 14 Cal. App. 5th 1179 (Ct. App. 2017).
cites § 387a 1×subsections: (a)cited by 16 cases
Where it cites § 387a
“In 2009, Congress superseded the holding of Brown & Williamson by in fact granting the FDA authority over tobacco products, including cigarettes. (21 U.S.C. § 387a(a) & (b).) In that statute, the Family Smoking Prevention and Tobacco Control Act, Congress specified that the…”
Later courts cite it for
“a court's error in excluding evidence is grounds for reversal only if the appellant demonstrates a miscarriage of justice, that is, that a different result would have been probable had the error not occurred.” · 7 citing courts
11
GREENCigar Ass'n of Am. v. U.S. Food & Drug Admin., 315 F. Supp. 3d 143 (D.C. Cir. 2018).
cites § 387a 2×subsections: (b)cited by 5 cases
Where it cites § 387a
“TCA § 901, codified at 21 U.S.C. § 387a (entitled "FDA authority over tobacco products").”
12
cites § 387a 1×subsections: (b)cited by 12 cases
Where it cites § 387a
“” 21 U. S. C. §387a(b). It also granted author- ity to regulate “any other tobacco products” that the FDA “by regulation deems” to meet the definition of a tobacco product.”
The case’s holding
An agency changes position when it acts inconsistently with its earlier position or declares prior action no longer good law, and must give a reasoned explanation and consider reliance interests.
Later courts cite it for
“free to change their existing policies as long as they provide a reasoned explanation for the change, display awareness that they are changing position, and consider serious reliance interests.” · 6 citing courts
13
GREENLiquid Labs LLC v. FDA, 52 F.4th 533 (3d Cir. 2022).
cites § 387a 1×subsections: (b)cited by 10 cases
Where it cites § 387a
“21 U.S.C. § 387a(b); see also 21 U.S.C. § 387j(a)(1)(A) (defining “a new tobacco product,” as relevant here, to be “any tobacco product .”
14
GREENAvail Vapor, LLC v. FDA, 55 F.4th 409 (4th Cir. 2022).
cites § 387a 1×subsections: (b)cited by 10 cases
Where it cites § 387a
“See 21 U.S.C. § 387a(b); 81 Fed. Reg. 28,974 (May 10, 2016) (“Deeming Rule”).”
The case’s holding
The Tobacco Control Act requires the FDA to conduct a comparative inquiry weighing a new tobacco product's risks against its benefits before authorizing its marketing.
Later courts cite it for
“the act explicitly contemplates that the fda must embark on a comparative inquiry before allowing any marketing of a new tobacco product.” · 2 citing courts
15
GREENU.S. Smokeless Tobacco Mfg. Co. v. City of New York, 708 F.3d 428 (2d Cir. 2013).
cites § 387a 1×subsections: (a)cited by 24 cases
Where it cites § 387a
“See 21 U.S.C. § 387a(a). Under the Act, the FDA’s authority extends to the regulation of “all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco and to any other tobacco products that the [FDA] by regulation deems to be subject to [the Act].”
The case’s holding
A local ordinance restricting the sale of flavored tobacco products is not preempted by federal law because the federal act preserves state authority to regulate and ban sales.
Later courts cite it for
“given congress's explicit decision to preserve for the states a robust role in regulating, and even banning, sales of tobacco products, we adopt a broad reading of the saving clause and a limited view of the kinds of restrictions that would constitute a ban and require us to address the permissibility of outright prohibitions under the saving clause.” · 4 citing courts
16
GREENJohn R. Grasso v. Gina Raimondo, 177 A.3d 482 (R.I. 2018).
cites § 387a 1×cited by 8 cases
Where it cites § 387a
“7 To determine to the contrary would require us to answer the following question posed by defendants in the affirmative: “Can a policeman, after being retired for accidental disability have a full recovery, become a major league baseball pitcher with a multimillion dollar annual…”
Later courts cite it for
“when a statutory section is clear and unambiguous, we apply the plain and ordinary meaning of the statute and we need not delve into any further statutory interpretation.” · 2 citing courts
17
GREENMoose Jooce v. FDA, 981 F.3d 26 (D.C. Cir. 2020).
cites § 387a 1×subsections: (b)cited by 8 cases
Where it cites § 387a
“21 U.S.C. § 387a(b) (2018). One such requirement is the preclearance pathway for manufacturers seeking to market a “modified risk tobacco product,” defined as “any tobacco product that is sold or distributed for use to reduce harm or the risk of tobacco-related disease…”
18
GREENVapor Tech. Ass'n v. FDA, 977 F.3d 496 (6th Cir. 2020).
cites § 387a 1×subsections: (b)cited by 7 cases
Where it cites § 387a
“21 U.S.C. § 387a(b). The Secretary carries out this responsibility through the FDA.”
19
GREENU.S. Smokeless Tobacco Mfg. Co. v. City of New York, 703 F. Supp. 2d 329 (S.D.N.Y. 2010).
cites § 387a 1×subsections: (b)cited by 13 cases
Where it cites § 387a
“Although the Act applies broadly to “all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco,” 21 U.S.C. § 387a(b), not all of the “tobacco product standards” promulgated by the Act apply to every type of tobacco product.”
20
GREENFDA v. R. J. Reynolds Vapor Co., 606 U.S. 226 (2025).
cites § 387a 1×cited by 5 cases
Where it cites § 387a
“See 21 U. S. C. §§387a, 393(d)(2). The Act expressly applies to many tobacco products that were popular when the Act was enacted in 2009, such as cigarettes.”
Later courts cite it for
“when congress uses 'one term in one place, and a materially different term in another, the presumption is that the different term denotes a different idea.” · 4 citing courts

Show all 59 citing cases (list view) →

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
201020182026

One bar per year. Tallest: 8 cases in 2025. 2026 is a partial year. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
D.D.C.85th Cir.7D.C. Cir.7Bankr. W.D.N.C.32d Cir.23rd Cir.24th Cir.26th Cir.2

The 8 courts with the most citing cases, of 30 courts in all.

By subsection
(a)13 cases
Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010).“" 21 U.S.C. § 387a(a). Moreover, unlike Brown & Williamson, which used the term "tobacco products" without defining it, the Tobacco Control Act includes a definition: "The term `tobacco product' means any product made or derived from tobacco that is intended for human…”
Major v. R.J. Reynolds Tobacco Co., 14 Cal. App. 5th 1179 (Ct. App. 2017).“In 2009, Congress superseded the holding of Brown & Williamson by in fact granting the FDA authority over tobacco products, including cigarettes. (21 U.S.C. § 387a(a) & (b).) In that statute, the Family Smoking Prevention and Tobacco Control Act, Congress specified that the…”
Colgate v. Juul Labs, Inc., 345 F. Supp. 3d 1178 (N.D. Cal. 2018).“A, § 2 (codified at 21 U.S.C. § 387a )(2009). On May 10, 2016, the FDA issued a final rule titled "Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale…”
U.S. Smokeless Tobacco Mfg. Co. v. City of New York, 708 F.3d 428 (2d Cir. 2013).“See 21 U.S.C. § 387a(a). Under the Act, the FDA’s authority extends to the regulation of “all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco and to any other tobacco products that the [FDA] by regulation deems to be subject to [the Act].”
Smoking Everywhere, Inc. v. U.S. Food & Drug Admin., 680 F. Supp. 2d 62 (D.D.C. 2010).“” 21 U.S.C. § 387a(a). 6 . The Court notes that the FDCA defines a "device” along the same lines as a "drug.”
Showing the top 5 of 13. More in the list view →
(b)37 cases
Nicopure Labs, LLC v. Food & Drug Admin., 266 F. Supp. 3d 360 (D.D.C. 2017).“” TCA § 901, codified at- 21 U.S.C. § 387a. This unequivocal assignment of responsibility goes on to provide: This chapter shall apply to all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco and to any other tobacco products that the Secretary by…”
Big Time Vapes, Inc. v. FDA, 963 F.3d 436 (5th Cir. 2020).“at 1786 (codified at 21 U.S.C. § 387a(b)). Each of those terms is statutorily defined.”
Wages & White Lion Invst v. FDA, 16 F.4th 1130 (5th Cir. 2021).“See 21 U.S.C. §§ 387a(b), 393(d)(2). The TCA prohibits manufacturers from selling any “new tobacco product” without authorization.”
Cigar Ass'n of Am. v. FDA, 964 F.3d 56 (D.C. Cir. 2020).“21 U.S.C. § 387a(b). The FDCA also now extends to “any other tobacco products” that the Secretary of Health and Human Services “by regulation deems to be subject to” the FDCA.”
Nicopure Labs, LLC v. FDA, 944 F.3d 267 (D.C. Cir. 2019).“21 U.S.C. § 387a(b). In addition to a default premarket authorization pathway, Congress created a more rigorous pathway for modified risk tobacco products.”
Showing the top 5 of 37. More in the list view →
(c)3 cases
Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010).
Smoking Everywhere, Inc. v. U.S. Food & Drug Admin., 680 F. Supp. 2d 62 (D.D.C. 2010).
Smoking Everywhere, Inc. v. U.S. Food & Drug Admin., No. 2009-0771 (D.D.C. Jan. 14, 2010).
(e)3 cases
1701 Express, INC v. HHS, No. 20-3155 (6th Cir. Nov. 12, 2020).
Station Mgmt. Consultants v. HHS, No. 20-2399 (3d Cir. May 25, 2021).
Rozema v. U.S. Dep't of Health & Human Servs., 167 F. Supp. 3d 324 (N.D.N.Y. 2016).

Show all 59 citing cases (list view) →

Enactment and amendments
(June 25, 1938, ch. 675, § 901, as added Pub. L. 111–31, div. A, title I, § 101(b)(3), June 22, 2009, 123 Stat. 1786; amended Pub. L. 117–103, div. P, title I, § 111(b), Mar. 15, 2022, 136 Stat. 789.)
Amendment years (notes): 2022
Versions

Edition shown: U.S. Code current through Pub. L. 119-102 (OLRC release point). Syfert holds no earlier or later version of this section.

U.S.C. Home  |  Search U.S. Code  |  Search cases for this section  |  syfert.com